Skip to main content

What your fourth-grade teacher knew that you didn't...



How do you imagine our memories work? Are there a thousand file cabinets in our heads, each dedicated to a different topic? Are there little minions running around organizing and re-organizing our stores of knowledge to incorporate all the things we learn every day? How come I can remember the atomic mass of Oxygen but I can’t remember the capital of Connecticut?

The truth is we still don’t really know. There are several theories about how we store knowledge but for the most part, it’s still up in the air. However, leaps and bounds have been made in the past 20 years to elucidate some of the mechanisms behind acquiring new knowledge. That is, scientists now think they know at least one way that we humans learn new things. 

The process is called Long-Term Potentiation and it is facilitated by events that occur at the synapse—the tiny space between two neurons where molecular signals govern cellular change. There is a molecule called the NMDA-receptor at some of your synapses that plays a role in modulating neurons’ responses to stimuli. The NMDA-receptor is like a little gate on the surface of a neuron that is receiving a signal. Depending on its state (open or closed) the signal from the first neuron will elicit a strong or weak response from the second neuron. If the receptor is “open,” special signaling molecules can go through it into the second neuron which starts responding. So far this sounds pretty normal, an open gate means more signal can get through and there will be more response. But how does that help me learn my vocabulary words?

Whether the NMDA-receptor is open or closed depends on two things: the amount of signal from the first neuron AND the amount of response from the second neuron. Not only will more signal from the first neuron open more NMDA-receptor channels but more response from the second neuron will also open more NMDA-receptor channels.  Furthermore, the more intense the signal-response event and the more often it occurs, the stronger the same signal-response event will be next time. The physiological change occurring at the molecular level strengthens the connection between the two neurons, which in turn strengthens the bit of knowledge associated with those neurons. This is precisely why the more times I copy a word and its definition, the more likely I am to remember it next week. I know you thought your fourth-grade teacher was just giving you busy-work, but that busy-work may have actually been helping you commit new facts to memory. 

So next time you’re tempted to skip a few homework problems think about your neurons. You may not feel it but every problem you do may make that connection between one neuron and the next a little bit stronger and your NMDA-receptors will thank you. In fact, I’m going to think about the capital of Connecticut for the rest of the day. Hartford…Hartford…Hartford……

Sources and further reading
Bliss, T. V. P.,  Collingridge, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.

Kikusui, Takefumi, Aoyagi, Atsushi, Kaneko, Tsugio (2000). Spatial Working Memory is Independent of Hippocampal CA1 Long-Term Potentiation in Rats. Behavioral Neuroscience 114, 700-706.

Tsien, Joe Z., Huerta, Patricio T., Tonegawa, Susumu (1996). The Essential Role of Hipposcampal CA1 NMDA Receptor-Dependent Synaptic Plasticity in Spatial Memory. Cell 87, 1327-1338.
Labels:

Comments

Post a Comment

Popular posts from this blog

AlphaFold2 Part 2: The ion channel challenge

Last month I wrote about the wonders and perils of the artificial intelligence program that predicts 3D protein structures, AlphaFold2. As an ion channel enthusiast , I naturally wanted to know how AlphaFold2 performs at predicting the structures of proteins embedded in cell membranes. When I search PubMed for articles that mention both "AlphaFold" and "ion channel" I only get 34 hits. This surprised me, given the hype and the general paranoia around AI replacing humanity. If we use these search results as a proxy for the state of the ion channel protein structure prediction field, I'd say the juice is still in the coconut. I wanted to know how well AF2 would do at predicting an ion channel protein structure, so I asked it to generate the structure of Kv2.1, a voltage-gated potassium ion channel that I studied during graduate school. Kv2.1 is a pretty important protein. It regulates neuron firing throughout the brain and body where it helps us learn new stuff, ...
Post a Comment
Read more

Precision murder -- wait, no -- medicine

A non-zero amount of what we call ‘medicine’ could be described as just controlled cell murder.  This was my revelation after researching a new treatment for certain cardiac arrhythmias called Pulsed Electric Field Ablation, which I became interested in when my father-in-law asked me how it worked during our Christmas visit. “How can it kill the heart cells and leave the nerves and blood vessels intact?” I had no idea. I know next-to-nothing about medical treatments for cardiac patients, much less how this Pulsed Field Ablation technique could have fewer side effects than the standard-of-care ablation techniques. A quick Google search piqued my curiosity when I learned that PFA is also sometimes called “high frequency irreversible electroporation”. While less catchy, that name revealed a bit more about the mechanism of action behind PFA - electroporation - which happens to be something I actually do know something about. Electroporation refers to the formation of holes (pores) in c...
Post a Comment
Read more

iPSCs, the new model organism?

Induced pluripotent stem cells. The name doesn't exactly roll off the tongue and it certainly doesn't conjure images of mice, fruit flies, monkeys, or any of the other classic model organisms used for basic biomedical research. These so called "model organisms" are just that; animals that help scientists model the way that the most promising human therapeutics in the collective pipeline will behave in humans. And now induced pluripotent stem cells, or iPSCs, are becoming an increasingly popular tool used for developing and testing novel drugs way before we expose any real human patients to them. The upside to using model organisms is pretty obvious -- we minimize exposure of humans to potentially unsafe molecules. The downsides are many, but one big one is that sometimes potential new drug molecules look really promising when they are given to a mouse with a human-like disease, but then that same molecule does nothing (or worse, is toxic!) when it goes into human clin...
Post a Comment
Read more